Bristol Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company focused on discovering, developing and delivering innovative medicines for people with serious diseases. Guided by the goal of transforming patients’ lives through science, the company conducts research and clinical development and shares scientific resources for patients, healthcare providers and researchers. Its areas of focus include oncology, hematology, neuroscience, immunology and cardiovascular disease. Across these fields, BMS works on conditions with significant unmet needs, pursuing disease-modifying and symptomatic therapies as well as advances in treatment for cancer and other complex illnesses.

The company offers a portfolio of medicines, medical information and support resources, including information on paying for medicines and access to investigational medicines. It also provides disease-state and therapeutic-area resources for patients and healthcare professionals. Its development pipeline spans compounds and disease areas under study, with clinical trials and research supporting the evaluation of potential therapies. Beyond research and medicines, Bristol Myers Squibb engages in patient advocacy, population health, environmental sustainability, social progress and corporate giving, including work through the Bristol Myers Squibb Foundation. It also provides information for investors, job seekers and partners.